These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 1706620)

  • 1. Major population differences in T cell response to a malaria sporozoite vaccine candidate.
    Zevering Y; Houghten RA; Frazer IH; Good MF
    Int Immunol; 1990; 2(10):945-55. PubMed ID: 1706620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A modified hepatitis B virus core particle containing multiple epitopes of the Plasmodium falciparum circumsporozoite protein provides a highly immunogenic malaria vaccine in preclinical analyses in rodent and primate hosts.
    Birkett A; Lyons K; Schmidt A; Boyd D; Oliveira GA; Siddique A; Nussenzweig R; Calvo-Calle JM; Nardin E
    Infect Immun; 2002 Dec; 70(12):6860-70. PubMed ID: 12438363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sporozoite malaria vaccine. Where do we stand?
    Nussenzweig V; Nussenzweig S
    Ann Parasitol Hum Comp; 1990; 65 Suppl 1():49-52. PubMed ID: 1702271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic T lymphocyte (CTL) low-responsiveness to the Plasmodium falciparum circumsporozoite protein in naturally-exposed endemic populations: analysis of human CTL response to most known variants.
    Doolan DL; Khamboonruang C; Beck HP; Houghten RA; Good MF
    Int Immunol; 1993 Jan; 5(1):37-46. PubMed ID: 7680226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A conserved peptide sequence of the Plasmodium falciparum circumsporozoite protein and antipeptide antibodies inhibit Plasmodium berghei sporozoite invasion of Hep-G2 cells and protect immunized mice against P. berghei sporozoite challenge.
    Chatterjee S; Wery M; Sharma P; Chauhan VS
    Infect Immun; 1995 Nov; 63(11):4375-81. PubMed ID: 7591073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2.
    Wizel B; Houghten RA; Parker KC; Coligan JE; Church P; Gordon DM; Ballou WR; Hoffman SL
    J Exp Med; 1995 Nov; 182(5):1435-45. PubMed ID: 7595214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasmodium falciparum synthetic LbL microparticle vaccine elicits protective neutralizing antibody and parasite-specific cellular immune responses.
    Powell TJ; Tang J; Derome ME; Mitchell RA; Jacobs A; Deng Y; Palath N; Cardenas E; Boyd JG; Nardin E
    Vaccine; 2013 Apr; 31(15):1898-904. PubMed ID: 23481177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune responses to multiple antigen peptides containing T and B epitopes from Plasmodium falciparum circumsporozoite protein of Brazilian individuals naturally exposed to malaria.
    Avila SL; Goldberg AC; Arruk VG; Marin ML; Guilherme L; Kalil J; Ferreira AW
    Parasite Immunol; 2001 Feb; 23(2):103-8. PubMed ID: 11240901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody responses to Plasmodium falciparum sporozoite-, liver- and blood-stage synthetic peptides in migrant and autochthonous populations in malaria endemic areas.
    Ferreira-da-Cruz MF; Deslandes DC; Oliveira-Ferreira J; Montenegro-James S; Tartar A; Druilhe P; Daniel-Ribeiro CT
    Parasite; 1995 Mar; 2(1):23-9. PubMed ID: 9137641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
    Dobaño C; Doolan DL
    Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunity to malaria elicited by hybrid hepatitis B virus core particles carrying circumsporozoite protein epitopes.
    Schödel F; Wirtz R; Peterson D; Hughes J; Warren R; Sadoff J; Milich D
    J Exp Med; 1994 Sep; 180(3):1037-46. PubMed ID: 7520465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of a non-repetitive sequence of Plasmodium falciparum circumsporozoite protein in man and mice.
    Del Giudice G; Cheng Q; Mazier D; Berbiguier N; Cooper JA; Engers HD; Chizzolini C; Verdini AS; Bonelli F; Pessi A
    Immunology; 1988 Feb; 63(2):187-91. PubMed ID: 2450833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition of synthetic 104-mer and 102-mer peptides corresponding to N- and C-terminal nonrepeat regions of the Plasmodium falciparum circumsporozoite protein by sera from human donors.
    Lopez JA; Roggero MA; Duombo O; Gonzalez JM; Tolle R; Koita O; Arevalo-Herrera M; Herrera S; Corradin G
    Am J Trop Med Hyg; 1996 Oct; 55(4):424-9. PubMed ID: 8916800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunogenicity of multiple antigen peptides (MAP) containing T and B cell epitopes of the repeat region of the P. falciparum circumsporozoite protein.
    Munesinghe DY; Clavijo P; Calle MC; Nussenzweig RS; Nardin E
    Eur J Immunol; 1991 Dec; 21(12):3015-20. PubMed ID: 1721025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide immunization can elicit malaria protein-specific memory helper but not proliferative T cells.
    Good MF; Branigan J; Smith G; Houghten RA
    Pept Res; 1990; 3(3):110-5. PubMed ID: 1724615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human lymphocyte proliferative response to a sporozoite T cell epitope correlates with resistance to falciparum malaria.
    Hoffman SL; Oster CN; Mason C; Beier JC; Sherwood JA; Ballou WR; Mugambi M; Chulay JD
    J Immunol; 1989 Feb; 142(4):1299-303. PubMed ID: 2464643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Plasmodium falciparum malaria vaccine candidate which contains epitopes from the circumsporozoite protein and a blood stage antigen, 5.1.
    Caspers P; Etlinger H; Matile H; Pink JR; Stüber D; Takács B
    Mol Biochem Parasitol; 1991 Aug; 47(2):143-50. PubMed ID: 1719416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of an alum-adsorbed synthetic multiple-antigen peptide based on B- and T-cell epitopes of the Plasmodium falciparum CS protein: possible vaccine application.
    de Oliveira GA; Clavijo P; Nussenzweig RS; Nardin EH
    Vaccine; 1994 Aug; 12(11):1012-7. PubMed ID: 7526570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T cell responses to repeat and non-repeat regions of the circumsporozoite protein detected in volunteers immunized with Plasmodium falciparum sporozoites.
    Nardin E; Munesinghe YD; Moreno A; Clavijo P; Calle MC; Edelman R; Davis J; Herrington D; Nussenzweig RS
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 3():223-7. PubMed ID: 1364202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+ T cell clones obtained from Plasmodium falciparum sporozoite-immunized volunteers recognize polymorphic sequences of the circumsporozoite protein.
    Moreno A; Clavijo P; Edelman R; Davis J; Sztein M; Sinigaglia F; Nardin E
    J Immunol; 1993 Jul; 151(1):489-99. PubMed ID: 7686946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.